Similar articles

• Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.

  Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J. Sackeim HA, et al. JAMA. 2001 Mar 14;285(10):1299-307. doi: 10.1001/jama.285.10.1299. JAMA. 2001. PMID: 11255384 Clinical Trial.
• Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.

  Tew JD Jr, Mulsant BH, Haskett RF, Joan P, Begley AE, Sackeim HA. Tew JD Jr, et al. Ann Clin Psychiatry. 2007 Jan-Mar;19(1):1-4. doi: 10.1080/10401230601163360. Ann Clin Psychiatry. 2007. PMID: 17453654 Clinical Trial.
• Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).

  Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. Kellner CH, et al. Arch Gen Psychiatry. 2006 Dec;63(12):1337-44. doi: 10.1001/archpsyc.63.12.1337. Arch Gen Psychiatry. 2006. PMID: 17146008 Free PMC article. Clinical Trial.
• What was learned: studies by the consortium for research in ECT (CORE) 1997-2011.

  Fink M. Fink M. Acta Psychiatr Scand. 2014 Jun;129(6):417-26. doi: 10.1111/acps.12251. Epub 2014 Feb 12. Acta Psychiatr Scand. 2014. PMID: 24571807 Review.
• Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses.

  Elias A, Phutane VH, Clarke S, Prudic J. Elias A, et al. Aust N Z J Psychiatry. 2018 May;52(5):415-424. doi: 10.1177/0004867417743343. Epub 2017 Dec 19. Aust N Z J Psychiatry. 2018. PMID: 29256252